I agree that this clearly indicates dosing has started. From a disclosure point of view the company indicated some time back the the trial had commenced so it sounds as though good progress has been made.
What isn't clear is whether all patients have been recruited and then dosing has commenced or whether dosing is occurring as patients are recruited? I guess we'll have to wait and see what the company says about that.
Its a phase 2 clinical trial so I don't expect results in 8 weeks. I'm guessing there would be a substantial period of data collection, analysis and verification that occurs post trial prior to publication.
In any event we are on our way it seems with our first human clinical trial - a substantial achievement in itself!
Ted.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-5398
-
-
- There are more pages in this discussion • 14,785 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online